UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
KDNY holding history
Chinook Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KDNY overviewAll 13F holders of KDNYFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −82,016−100.0% | Sold out | Holders |
| Q2 2023 | 82,016 | $3.15M | <0.1% | +5,028+6.5% | Added | Holders |
| Q1 2023 | 76,988 | $1.78M | <0.1% | +8,224+12.0% | Added | Holders |
| Q4 2022 | 68,764 | $1.80M | <0.1% | +45,316+193.3% | Added | Holders |
| Q3 2022 | 23,448 | $461.0K | <0.1% | +9,322+66.0% | Added | Holders |
| Q2 2022 | 14,126 | $248.0K | <0.1% | −60,288−81.0% | Reduced | Holders |
| Q1 2022 | 74,414 | $1.22M | <0.1% | +29,388+65.3% | Added | Holders |
| Q4 2021 | 45,026 | $735.0K | <0.1% | +19,944+79.5% | Added | Holders |
| Q3 2021 | 25,082 | $320.0K | <0.1% | +23,958+2,131.5% | Added | Holders |
| Q2 2021 | 1,124 | $16.0K | <0.1% | +1,124 | New | Holders |